Paroxetine cuts tamoxifen effectiveness in breast cancerOntario study links the drug combo with increased mortality Prostate biopsy complication rate risingCanadian data reveal most hospital admissions for these adverse events are due to infections Trial drug overcomes resistant chronic myeloid leukemia Omacetaxine battles genetic mutation that negates existing therapy Adjuvant therapy has feverish results in real-world care Febrile neutropenia observed at higher than expected rate Chemo- trastuzumab combo ups survival FPs should take lead in reducing breast cancer risk Online tool helps family doctors screen women to detect higher-risk patients Nilotinib bests imatinib in chronic myeloid leukemia Questions about tolerability and cost of treatment need answering before clinical practice should change Rethinking breast cancer Statins benefit leukemia patients Clinical trials needed to pinpoint ideal candidates Study finds no difference in adjuvant therapy strategies Continuous aromatase inhibitor therapy no better than starting with tamoxifen Study OKs dose boost for estrogen receptor antagonist Wait times for diagnosis exceed accepted targets First Previous 66 67 68 69 70 Next Last
